Qifeng Xie

发表

Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study

Zhifeng Liu, J. Ji, Jinghua Gao, 2020, BMC Infectious Diseases.

Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: A multicenter retrospective cohort study

Zhifeng Liu, J. Ji, Conglin Wang, 2020, Journal of Infection.

Glucocorticoid therapy does not delay viral clearance in COVID-19 patients

Zhifeng Liu, J. Ji, Jinxia Zhang, 2020, Critical Care.

1 Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients with COVID-19: A multicenter retrospective cohort study

Ming, Zhifeng Liu, Wang, 2020 .

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study

Zhifeng Liu, Huiheng Liu, J. Ji, 2020, medRxiv.

Effects of hypertension on the outcomes of COVID-19: a multicentre retrospective cohort study

Yuting Wu, Zhifeng Liu, J. Ji, 2021, Annals of medicine.

Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study

Zhifeng Liu, Yong-ming Yao, Conglin Wang, 2020, International Immunopharmacology.

Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines.

M. Kurimoto, K. Kawakami, A. Saito, 1999, Cellular immunology.

Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12

K. Kawakami, A. Saito, X. Qifeng, 1997, Infection and immunity.